UCM710, > = 98 %(HPLC)

Code: SML0514-25MG D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

UCM710 is a dual inhibitor of fatty acid amide hydrolase (FAAH) and A/β hydrolase domain 6 (ABHD6) the enzymes that hydrolyze endocannabinoids. U...


 En savoir plus

Votre prix
$437.52 25MG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

UCM710 is a dual inhibitor of fatty acid amide hydrolase (FAAH) and A/β hydrolase domain 6 (ABHD6) the enzymes that hydrolyze endocannabinoids. UCM710 augments both N-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG) levels in neurons. UCM710 does not inhibit monoacylglycerol lipase (MAGL).

Features and Benefits

This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Packaging

5, 25 mg in glass bottle

assay≥98% (HPLC)
colorcolorless to light yellow
formoil
InChI keyFWEHVPCBXKCYHE-FPLPWBNLSA-N
InChI1S/C19H34O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(20)22-17-18-16-21-18/h7-8,18H,2-6,9-17H2,1H3/b8-7-
Quality Level100
SMILES stringCCCCCCC=C/CCCCCCCC(=O)OCC1CO1
storage temp.2-8°C
Cas Number213738-77-3
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.